SCI时时刷

search
Challenges in the management of primary central nervous system lymphoma
Primary central nervous system lymphoma (PCNSL) is an invasive extranodal non-Hodgkin lymphoma (NHL) confined to the centr...
Application of VEGF/VEGFR peptide vaccines in cancer: A systematic review of clinical trials
Angiogenic factors are crucial in the development of human cancers, and the most prominent is VEGF/VEGF receptors (VEGFRs)...
The 2022 Assisi Think Tank Meeting: White paper on optimising radiation therapy for breast cancer
Liesbeth Boersma, MD is radiation oncologist at Dept. Radiation Oncology making and innovation implementation. She is memb...
Therapeutic strategies targeting metabolic characteristics of cancer cells
Jiuwei Cui, chief physician, professor, doctoral tutor. She engaged in research on accurate diagnosis and treatment of tum...
Revisiting the role of alkylating agents in multiple myeloma: Up-to-date evidence and future perspectives
Multiple myeloma (MM) is a hematologic neoplasm characterized by a bone marrow (BM)-predominant proliferation of malignant...
Erythrocytes: Member of the immune system that should not be ignored
Erythrocytes (red blood cells, RBCs) are the most abundant blood cell in the blood and are the primary vehicle carrying ox...
Novel therapeutic strategies for recurrent SCLC
SCLC is an aggressive disease that accounts for approximately 15% of all lung cancer cases. Despite significant advancemen...
The prognostic role of p53 mutations in metastatic colorectal cancer: a systematic review and meta-analysis
Alessandro Ottaiano is an Oncologist working at the SSD-Innovative Therapies for Abdominal Metastases at the Department of...
IL-32 and its paradoxical role in neoplasia
In 1992, the cytokine-like natural killer cell transcript 4 (NK4) was discovered, which was shown to be selectively expres...
LncRNAs and related molecular basis in malignant pleural mesothelioma: Challenges and potential
Malignant pleural mesothelioma (MPM) is a rare but invasive cancer, which mainly arises from mesothelial tissues of pleura...
Clinical and molecular overview of immunotherapeutic approaches for malignant skin melanoma: Past, present and future
Melanomas are malignant tumors formed by the uncontrolled proliferation of atypical and genetically mutated melanocytes (C...
Nano based-oncolytic viruses for cancer therapy
Cancer is one of the world's largest health problems.Based on global demographic characteristics, the incidence of cancer ...
DOSE AND VOLUME DE-ESCALATION OF RADIOTHERAPY IN HEAD AND NECK CANCER
Dr. Maria Jesus Garcia Anaya is currently a staff member in the Department of Radiation Oncology at the University Hospita...
Recent Advances and Research Progress in Biomarkers for Chronic Graft Versus Host Disease
Chronic graft versus host disease (cGVHD) is a major cause of nonrelapse morbidity and mortality and occurs in approximate...
Thrombosis and cachexia in cancer: two partners in crime?
Cancer is a prominent cause of mortality and a significant obstacle to improving life expectancy. Worldwide, the tumour ty...
“A Review of HER2 overexpression and somatic mutations in cancers”
Human Epidermal Growth Factor Receptor 2 (HER2) is a gene that encodes a growth factor receptor, which activates intracell...
Use of tumour bed boost radiotherapy in volume replacement oncoplastic breast surgery: A systematic review
Icro Meattini is Associate Professor at the Department of Clinical and Experimental Biomedical Sciences of the University ...
Late effects of childhood cancer survivors in Africa: A scoping review
Gertjan Kaspers is pediatric oncologist, professor at Amsterdam UMC and director Academy & Outreach at Princess Máxima...
Induction chemotherapy in locally advanced head and neck cancers, is there a best choice?
Hoda Mahdavi is an assistant professor in radiation oncology, and a medical educator of Iran University of Medical Science...
Current status of locally advanced rectal cancer therapy and future prospects
Colorectal cancer (CRC) is the third most commonly diagnosed malignancy. It accounts for more than 50,000 deaths annually ...